SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-066553
Filing Date
2024-05-30
Accepted
2024-05-30 16:04:17
Documents
11
Period of Report
2024-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-20240530.htm   iXBRL 8-K 50355
  Complete submission text file 0000950170-24-066553.txt   162871

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20240530.xsd EX-101.SCH 23897
14 EXTRACTED XBRL INSTANCE DOCUMENT rare-20240530_htm.xml XML 4516
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 241005133
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)